CS Paper Radar

Multi-Assay Antibody Developability Prediction with Shared Structure-Language Representations

Daria B. Kokh

cs.LG q-bio.BM ·submitted 2026-11-13 19:04 UTC · v1

Abstract

Early assessment of antibody developability is critical in drug discovery, but computational approaches remain limited by the scarcity of experimental data. We explore two strategies for working within that limit. First, we designed per-residue physicochemical descriptors encoding the local structural environment, including new terms such as directional charge asymmetry and screened electrostatic potential. These feed a convolutional network, combined with protein language model (PLM) embeddings in a two-stream architecture: the two are encoded and predicted independently and merged only at the prediction stage. Second, a shared trunk with per-assay heads passes information between related assays. Both are implemented in the Multi-Assay Developability Model (MADM) and evaluated on eight assays: HIC, heparin affinity (HAC), AC-SINS, and polyspecificity ELISA against BVP, dsDNA, insulin, ovalbumin and soluble membrane proteins (SMP), with labels from 29 open sources. Structural descriptors match or exceed PLM embeddings (AbLang2, ESM2) on several assays; combining the streams gives a small but consistent gain in accuracy and reduces seed-to-seed variance. Multi-assay training raises Spearman rho for ovalbumin and SMP by about 0.1, where assays correlate and share sequence space. Under cluster-split cross-validation the strongest results are for HAC, ovalbumin, insulin, SMP and HIC (rho = 0.70-0.82); AC-SINS, BVP and dsDNA are weaker (0.50-0.55). In these three, sequence clusters largely coincide with data source, so a held-out fold measures transfer to differently calibrated measurements as well as to new sequences. On the 80-antibody GDPa3 hold-out, performance falls by rho around 0.1 for all but SMP (0.22). Transfer to the VHH panel of Ginkgo GDPa5 gives comparable results, and scFv validation against binary SMP labels yields F1 = 0.89, AUC = 0.95.

Comment
27 pages, 11 figures, 4 tables, Supplementary Material

Closest papers

Nearest neighbours by meaning across the whole index.

Interpreting Protein Language Model Embeddings via Orthogonal Projection for Protein Fitness Prediction

cs.LG q-bio.QM ·2026-08-26 ·Paulo Yanez Sarmiento, Pia Francesca Rissom, Manuel Pfeuffer, Marco Simnacher, Jordan F. Safer +4 more
similarity 0.62
Abstract · Preprint

Recently, there has been a growing adoption of protein language models (PLMs) in biomedical science. Their embeddings provide a rich numerical representation of protein sequences which achieve state-of-the-art performance on several downstream tasks including protein fitness prediction. However, PLM embeddings are not directly interpretable and, thereby, it remains unclear what features they encode. To gain insight into which biochemical properties of the protein are driving the prediction, we leverage an orthogonal projection technique that removes linear effects of known tabular features from embeddings and extend it to high-order and interaction effects. In this way, we remove the effects of interpretable biochemical features from PLM embeddings. In an ablation study, we show that this leads to a decrease in performance for a downstream classifier trained only on the embeddings to predict protein fitness. In an additional evaluation, we find that these biochemical features explain a substantial part of the variance in the predictions of this classifier. Hence, we can show that PLM embeddings encode patterns correlated with biochemical properties and quantify their contribution to predicting protein fitness. This computationally efficient approach is not limited to the features or embeddings considered here and is readily transferable to problem settings beyond protein fitness prediction.

0.20

InstructPro2: Natural Language and Biological Grounding Guided De Novo Protein Design

cs.LG ·2026-10-14 ·Charles Novak, Zhenqiao Song, Chuan Li, Jianwen Xie, Lei Li
similarity 0.61
Abstract · 19 pages, 6 figures

The ability to generate proteins with desired functions is a central goal of computational biology. Although natural language can express diverse design objectives, existing protein generation methods often support only narrow tasks or make limited use of biological constraints. We develop InstructPro2 to translate natural-language design objectives into protein sequences while incorporating task-specific biological context. A text encoder captures the design instructions, while dedicated ligand and antigen encoders provide biological context to the sequence-generating decoder. For pretraining, we assemble InstructPro2Bench, comprising 205.7 million <function description, protein> pairs from UniProtKB. We subsequently adapt the model to ligand-binding protein and antibody design. On functional protein generation benchmarks, InstructPro2 outperforms Pinal, the strongest baseline, achieving a functional recovery F1 of 74.8 versus 62.2 and lowering global RMSD from 5.33A to 3.04A. For antibody design, the model obtains a DockQ score of 0.39, while ligand-binding protein design reaches a docking success rate of 72.6%. These findings highlight how integrating language-based instructions with biological conditioning can extend protein generation to distinct design settings.

0.14

A curated multi-endpoint drug-protein bioactivity dataset with construct-aware protein targets

cs.LG ·2026-10-23 ·Lina Abou-Abbas, Nour Mhanna, Hasan Bazzi, Sleiman El Hajj, Abdulkader Helwan +2 more
dataset similarity 0.59
Abstract

Public drug-protein bioactivity resources commonly identify targets by UniProt accession, although one accession may represent distinct experimental sequences. We present Curate-DTI, a construct-aware dataset derived from the 1 July 2026 BindingDB export, with IC50, Ki, Kd and EC50 processed independently. The release contains 2,919,717 measurements, 1,291,872 standardized ligands, 9,668 sequence-defined protein entities and 2,275,683 endpoint-specific interactions spanning 8,336 reviewed UniProt accessions. Protein entities combine the accession with the reported experimental sequence, preserving constructs that accession-only processing would merge. Across the four endpoints, 4,204 endpoint-specific ligand-accession groups showed different classification labels across sequence-defined protein entities. Exact and inequality-qualified observations provide relation-aware classification evidence, whereas regression targets use exact values only. Connected Parquet tables preserve individual measurements, standardized structures, protein sequences, aggregated interactions and available assay and source provenance. The resource supports endpoint-specific classification and regression while allowing users to select molecular representations, protein representations and evaluation splits. Preprocessing code, a column dictionary, exclusion reports and validation summaries accompany the release.

0.26

AbGaze: Attentive Geometric Representation Learning for End-to-End Antibody Design

cs.AI ·2026-09-28 ·Jiashuo Wang, Siqi Fan, Yizhen Luo, Zaiqing Nie
similarity 0.59
Abstract

Computational antibody design requires representations that capture the geometric patterns underlying antigen--antibody interactions, yet existing approaches often rely on scalar distances or surface-intrinsic features, leaving cross-molecular geometry largely implicit. We present AbGaze, an end-to-end antibody design framework based on attentive geometric representation learning, which encodes distance, spatial direction, and surface-normal orientation of antigen surfaces relative to antibody-residue local frames, and adaptively aggregates these geometric interactions according to their interfacial context. The learned interaction representation is shared across multi-CDR co-design, complex structure prediction, and affinity optimization, with local-frame geometric supervision further constraining the representation. AbGaze outperforms prior methods across all three tasks: relative to the second-best method, it improves amino-acid recovery by 7.1% and reduces structural error by 14.9% on average over the six CDRs, improves interface docking quality (DockQ) by 6.6%, and raises the affinity improvement rate (IMP) by 32.5%.

0.28

Chemical and geometric representation fidelity improves drug--target affinity prediction

cs.AI q-bio.BMcs.LGstat.ML ·2026-09-02 ·Yixiao Li, Yining Qian, Yefan Chen, Zenghui Chen, Jiayue Sun +3 more
benchmark similarity 0.58
Abstract · 21 pages, 10 figures

Predicting drug--target binding affinity (DTA) requires models to distinguish subtle chemical and structural determinants underlying molecular recognition. Although recent approaches increasingly incorporate richer drug and protein information, such information may be compressed, homogenized or discretized during representation construction, causing affinity-relevant distinctions to be lost before interaction modelling. We hypothesized that this representation-stage information loss constitutes an upstream bottleneck that cannot be reliably overcome by increasingly complex interaction predictors. To test this hypothesis, we developed ReGeoDTA, a representation-preserving framework that maintains affinity-relevant chemical heterogeneity in molecular representations and continuous geometric relationships in protein structures. Across three benchmark datasets, ReGeoDTA consistently improved affinity prediction, and the proposed representation-preserving strategies retained their benefits across diverse DTA architectures. Controlled representation degradation progressively reduced predictive performance, whereas increasing downstream predictor complexity failed to recover information lost during representation construction. These findings identify representation fidelity as an upstream design principle for accurate and generalizable drug--target affinity prediction, with potential implications for computational compound prioritization.

0.23

Revisiting Structure-Based Filtering for AI-Designed Antibodies: Opportunities, Limits, and What Matters

cs.CE ·2026-10-16 ·Langzhang Liang, Juncheng Qian, Xiaojie Ma, Mingxi Zou, Yinghui Xu +2 more
similarity 0.58
Abstract · 29 pages, 4 figures

AI antibody design can generate far more candidates than can be experimentally tested, making post-generation filtering a central bottleneck. We study whether structure-prediction outputs can help prioritize AI-designed antibodies for experimental validation. We evaluate this problem on 4,184 experimentally characterized antibody-antigen pairs, combining newly generated wet-lab measurements with curated affinity data across diverse antigens and assay settings. We introduce two complementary filtering signals: Regional Interaction Contrast (RIC), which captures support for the predicted antibody-antigen interface, and Non-CDR Antibody Confidence (NAC), which measures antibody confidence outside the CDRs. Across AlphaFold 3, Protenix-v2, and ESMFold2, we find a striking difference in what information matters for filtering. Interface evidence is strongest when comparing candidates designed for different antigens, whereas antibody-level reliability is substantially more informative for ranking candidates within the same antigen. In particular, non-CDR antibody confidence consistently outperforms whole-antibody confidence across predictors, revealing an unexpected source of filtering signal beyond the predicted interface. Finally, we examine the information encoded in the predictor outputs themselves. Predicted structures contain substantial but incomplete binding-related signal, revealing both the opportunities and limits of structure-based filtering: better metrics can exploit current predictors more effectively, but their performance ultimately remains constrained by what those predictors can distinguish.

0.32

Learning Task-Specific Antibody Representations via Function-Aware Masking

cs.LG q-bio.BM ·2026-09-01 ·Ayan Goel, Thomas A. Walton, Amirali Aghazadeh
published similarity 0.58
Abstract · Accepted to MLCB 2026 (Oral)

Antibody-specific language models pretrained via masked language modeling (MLM) learn representations that are critical for downstream sequence design and property prediction tasks. Yet, the corruption process itself is rarely leveraged as a source of inductive bias during pretraining. While preferentially masking complementarity-determining regions (CDRs) improves binding-related predictions, antibodies possess diverse biological priors over a variety of functions. Herein, we introduce function-aware masking, a family of pretraining algorithms that align mask placement with specific functional priors (e.g., from IMGT annotations or structure predictions) to shape the learned representation space. We show that these specialist masking strategies significantly improve performance on their respective objectives, yielding up to a 14% gain on structure-related tasks and up to a 5.9x improvement on CDR-related tasks. To further improve performance across multiple functional axes, we develop hybrid masking strategies that integrate multiple priors, balancing reconstruction over binding, structural, and biophysical objectives. Our results demonstrate that informed mask placement provides a parameter-free mechanism for imposing functional inductive biases in antibody language model training.

0.31

HierDTA: Hierarchical Structure-Aware Representation Learning for Drug--Target Affinity Prediction

cs.LG cs.AI ·2026-10-19 ·Huangchao Xu, Baohua Zhang, Qian Liu, Zhong Jin, Yi Du
published similarity 0.58
Abstract · 20 pages, 7 figures

Drug--target affinity (DTA) prediction plays an important role in computer-aided drug discovery, where reliable computational models can help prioritize compound--protein pairs before experimental validation. A key challenge in DTA prediction is to effectively mine multi-level molecular information from drug structures while accurately modeling the binding-site environment of target proteins. To address these issues, we introduce HierDTA, a hierarchical structure-aware framework for DTA prediction. \textcolor{black}{HierDTA represents each drug as an atom--motif heterogeneous graph and introduces an augmentation module that propagates functional-motif semantics to the corresponding atoms. For proteins, kinase-domain structures are converted into residue interaction graphs. The resulting atom and residue representations are integrated using cross-attention to capture pair-specific relationships, while molecule fingerprints and pretrained ESM-2 embeddings provide complementary global information. Compared with state-of-the-art methods, HierDTA achieves superior performance on the Davis dataset across all metrics and attains the highest \(r_m^2\) of 0.791 on KIBA. It also exhibits strong generalization under cold-start settings, particularly on KIBA, where MSE is reduced by 21.7\% in the unseen-protein scenario. Ablation study and interpretability analysis supported the contributions of the hierarchical augmentation and interaction components.} Case studies further showed that HierDTA provided early enrichment of candidate bioactive compounds. These results indicate that HierDTA is an effective framework for affinity prediction and target-specific virtual screening.

0.31